C3.ai CEO Ehikian Granted 1.14M RSUs and 1.28M Options at $17.53
Stephen Bradley Ehikian, Chief Executive Officer of C3.ai (AI), received equity awards on 09/15/2025 consisting of 1,140,902 RSUs and a stock option for 1,282,139 shares with a $17.53 exercise price.
Rhea-AI Filing Summary
Stephen Bradley Ehikian, Chief Executive Officer of C3.ai (AI), received equity awards on 09/15/2025 consisting of 1,140,902 RSUs and a stock option for 1,282,139 shares with a $17.53 exercise price. The RSUs convert to one share each on settlement; 399,316 RSUs vest on December 30, 2025 and the remainder vest in 11 equal quarterly installments thereafter provided continued service. The option vests 5% on December 15, 2025 and 5% quarterly thereafter and expires on September 14, 2035. The reported beneficial ownership figures after the transactions are 1,140,902 shares for RSUs and 1,282,139 underlying shares for the option. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Positive
- Explicit multi-year vesting schedule for RSUs and options supports retention through December 2025 and beyond
- Clear disclosure of award sizes: 1,140,902 RSUs and 1,282,139-option-underlying shares reported
Negative
- Potential dilution from settlement of 1,140,902 RSUs and exercise of 1,282,139 options
- Long-duration option (expires 09/14/2035) extends potential share issuance far into the future
Insights
TL;DR: CEO received large RSU and option grants with multi-year vesting, affecting potential future share count but routine for executive compensation.
The awards reported show a substantial equity grant: 1,140,902 RSUs and an option covering 1,282,139 shares at a $17.53 strike. Vesting schedules spread settlement over multiple quarters beginning in December 2025, which staggers dilution and aligns compensation with continued service. The option's long-term expiration to 09/14/2035 gives the holder decade-plus to exercise once vested. From an analytical perspective, these are material in size but consistent with retention and incentive practices; the filing does not disclose immediate cash proceeds or exercise activity.
TL;DR: Governance view: structured vesting ties rewards to tenure; disclosure is standard and provides clear vesting terms.
The Form 4 discloses explicit vesting mechanics: a fixed tranche of 399,316 RSUs vesting on a single date and remaining RSUs in 11 equal quarterly installments, plus option vesting at 5% initially and 5% quarterly thereafter. These provisions are clearly documented and meet Section 16 reporting requirements. The filing contains no amendment history and was executed by an attorney-in-fact, which is typical. No additional governance concerns or departures are disclosed within the form.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,282,139 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock | 1,140,902 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 399,316 shares of such RSU award shall vest on December 30, 2025 and the remaining RSUs shall vest thereafter in a series of 11 equal, successive quarterly installments, so long as the Reporting Person continues to provide services through such vesting dates.
- F2. 5% of the option shall vest on December 15, 2025 and 5% of the option shall vest quarterly thereafter, so long as the Reporting Person continues to provide services through such vesting dates.
FAQ
What equity awards did C3.ai CEO Stephen Bradley Ehikian receive on 09/15/2025?
When do the RSUs awarded to the CEO begin to vest?
What is the vesting schedule for the stock option granted to the CEO?
What exercise price applies to the option disclosed on the Form 4?
Who signed the Form 4 and when was it filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.